32 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
; reputational harm; diminished profits; and the curtailment or restructuring of our operations. If any of the physicians or other providers or Table of Contents … , industrial espionage attacks, or insider threat attacks, which could result in financial, legal, business, or reputational harm. Our employees, clinical
ARS
rqh8yrhk4c6xcbfzc2mi
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
ojkl 88dr
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.42
airuenvfczn yc2
21 Mar 22
Annual report
4:19pm
10-K
EX-10.39
oj39bxe
21 Mar 22
Annual report
4:19pm
10-K
v2p3s3qvpi58v
21 Mar 22
Annual report
4:19pm
8-K
EX-10.4
320gu fh4jqjo4t
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.1
l1v672bmg
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.3
moa3nizb3ntfg tvwbi
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.2
uvijy9y0
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
424B4
isvd8 pqmtmst
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-10.40
xvie2yx8wfb
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.30
21j58ij1ukmza3nwo
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.34
rk311cwxc0a
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
zlr0a2 mt
19 Jul 21
IPO registration (amended)
6:09am